Clover Health Investments, Corp.
CLOVNasdaqCIK 1801170FinancialsFiscal year ends Dec 31
Reports and events: 149 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-06-1413:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-24-000124 |
| 2024-06-1320:06 ET | 8-K | 5.07 Shareholder vote results | 0001801170-24-000122 |
| 2024-05-2912:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-24-000119 |
| 2024-05-0720:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001801170-24-000102 |
| 2024-05-0720:07 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-24-000101 |
| 2024-04-2620:05 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0001801170-24-000094 |
| 2024-04-2220:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-24-000089 |
| 2024-04-0520:05 ET | 8-K | 3.01 Delisting notice | 0001801170-24-000085 |
| 2024-04-0420:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-24-000082 |
| 2024-03-1411:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001801170-24-000064 |
| 2024-03-1220:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-24-000063 |
| 2024-01-1013:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-24-000043 |
| 2023-12-2713:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-23-000126 |
| 2023-12-2113:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000125 |
| 2023-12-0113:16 ET | 8-K | 2.05 Exit or disposal costs; 2.06 Material impairments; 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000115 |
| 2023-11-0621:09 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001801170-23-000104 |
| 2023-11-0621:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-23-000103 |
| 2023-11-0320:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-23-000094 |
| 2023-08-2820:05 ET | 8-K | 8.01 Other events | 0001801170-23-000063 |
| 2023-08-0820:11 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001801170-23-000060 |
| 2023-08-0820:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-23-000059 |
| 2023-08-0320:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000055 |
| 2023-07-2112:17 ET | DEF 14A | Proxy statementPeriod 2023-08-30 | 0001801170-23-000050 |
| 2023-06-2221:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000043 |
| 2023-06-0901:00 ET | 8-K | 5.07 Shareholder vote results | 0001801170-23-000041 |
| 2023-06-0811:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-23-000040 |
| 2023-05-0920:39 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001801170-23-000038 |
| 2023-05-0920:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-23-000037 |
| 2023-04-2612:46 ET | DEF 14A | Proxy statement | 0001801170-23-000031 |
| 2023-04-2420:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000026 |
| 2023-04-2121:00 ET | 8-K | 3.01 Delisting notice | 0001801170-23-000024 |
| 2023-04-2020:06 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001801170-23-000021 |
| 2023-03-1720:51 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001801170-23-000020 |
| 2023-03-0112:01 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001801170-23-000015 |
| 2023-02-2811:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-23-000012 |
| 2023-02-0221:42 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001801170-23-000011 |
| 2023-01-2022:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-23-000008 |
| 2023-01-1014:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001801170-23-000004 |
| 2022-11-3021:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-22-000090 |
| 2022-11-0721:12 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001801170-22-000083 |
| 2022-11-0721:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001801170-22-000082 |
| 2022-10-0401:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001341004-22-000247 |
| 2022-09-2320:50 ET | 8-K | 5.07 Shareholder vote results | 0001801170-22-000071 |
| 2022-08-1213:05 ET | DEF 14A | Proxy statementPeriod 2022-09-22 | 0001801170-22-000060 |
| 2022-08-1010:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-22-000056 |
| 2022-08-0820:21 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001801170-22-000053 |
| 2022-08-0820:11 ET | 8-K | 9.01 Financial statements and exhibits | 0001801170-22-000051 |
| 2022-07-2620:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-22-000038 |
| 2022-05-2720:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001801170-22-000034 |
| 2022-05-2520:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001801170-22-000032 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.